Credo Diagnostics Biomedical is finalizing a rapid point-of-care molecular test for the detection of novel Coronavirus COVID-19 in 20 minutes
To date, the novel Coronavirus has killed more than 2,000 people with more than 75,000 confirmed cases worldwide. Leveraging its real-time PCR point-of-care platform, the VitaPCRTM, which was introduced during the American Association of Clinical Chemistry Conference (AACC) in Anaheim last year, the test will deliver results in 20 minutes with a hands-on time of […]
